EUVIMEDEUVIMED entdecken
Crossref

Investigating the interaction pattern of FDA approved compounds with Mycobacterium tuberculosis GidB to understand their potential as antibiotics

Tasmin Nazim, Vipul Kumar, Faraz Ahmed, Nasreen Z Ehtesham, Seyed E Hasnain, Durai Sundar, Sonam Grover

Journal of Biomolecular Structure and Dynamics · 2024

DOI: 10.1080/07391102.2024.2434026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomolecular Structure and Dynamics, 2024. Verfasst von Tasmin Nazim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Jamia Hamdard, New Delhi, India. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Bacterial Proteins, Methyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Science Chair, Science and Engineering Research Board, Department of Science and Technology, Government of India, Robert Koch Institute, ICMR-Emeritus Scientist.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsBacterial ProteinsMethyltransferasesAnti-Bacterial AgentsMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingUnited StatesDrug ApprovalUnited States Food and Drug AdministrationHumans

Stichwörter der Autor:innen

ArbutinMDRRv3919cTBXDRdipyrithionemedronic acidmethyltransferasezoledronic acid

Substanzen

Antitubercular AgentsBacterial ProteinsMethyltransferasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Molecular Medicine, Jamia Hamdard, New Delhi, India.
  • Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology, New Delhi, India.
  • Department of Life Sciences, School of Basic Science and Research, Sharda University, Greater Noida, India.

Förderung

  • National Science Chair, Science and Engineering Research Board, Department of Science and Technology, Government of India
  • Robert Koch Institute
  • ICMR-Emeritus Scientist

Zitieren

APA

Nazim, T., Kumar, V., Ahmed, F., Ehtesham, N. Z., Hasnain, S. E., Sundar, D., & Grover, S. (2024). Investigating the interaction pattern of FDA approved compounds with Mycobacterium tuberculosis GidB to understand their potential as antibiotics. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2024.2434026

Vancouver

Nazim T, Kumar V, Ahmed F, Ehtesham NZ, Hasnain SE, Sundar D, et al. Investigating the interaction pattern of FDA approved compounds with Mycobacterium tuberculosis GidB to understand their potential as antibiotics. Journal of Biomolecular Structure and Dynamics. 2024. doi:10.1080/07391102.2024.2434026

BibTeX
@article{Nazim2024,
  author = {Nazim, Tasmin and Kumar, Vipul and Ahmed, Faraz and Ehtesham, Nasreen Z and Hasnain, Seyed E and Sundar, Durai and Grover, Sonam},
  title = {Investigating the interaction pattern of FDA approved compounds with Mycobacterium tuberculosis GidB to understand their potential as antibiotics},
  journal = {Journal of Biomolecular Structure and Dynamics},
  year = {2024},
  doi = {10.1080/07391102.2024.2434026}
}
Kostenlos starten →